Agilent to Showcase Next-Generation Digital Pathology Solutions at USCAP 2025
Agilent Technologies (NYSE: A) will showcase its digital pathology solutions at the USCAP Conference in Boston, March 22-27, 2025. The company has developed an end-to-end digital pathology workflow in collaboration with Hamamatsu, PathAI, Proscia, and Visiopharm, integrating AI-driven precision pathology software with automated staining solutions.
The showcase will feature live demonstrations of scanning, image management, and AI-driven image analysis capabilities. Key products to be displayed include the Magnis NGS Prep System and NovoCyte Opteon Spectral Flow Cytometer.
Two symposiums are scheduled for March 24: a Digital Pathology Symposium on innovations and insights (12:00-1:00 PM ET) and a Medical Affairs Symposium focusing on PD-L1 Heterogeneity (5:30-7:00 PM ET).
Agilent Technologies (NYSE: A) presenterà le sue soluzioni di patologia digitale alla Conferenza USCAP a Boston, dal 22 al 27 marzo 2025. L'azienda ha sviluppato un flusso di lavoro di patologia digitale end-to-end in collaborazione con Hamamatsu, PathAI, Proscia e Visiopharm, integrando software di patologia di precisione guidato dall'IA con soluzioni di colorazione automatizzate.
La presentazione includerà dimostrazioni dal vivo delle capacità di scansione, gestione delle immagini e analisi delle immagini guidata dall'IA. I principali prodotti che saranno esposti includono il Magnis NGS Prep System e il NovoCyte Opteon Spectral Flow Cytometer.
Due simposi sono programmati per il 24 marzo: un Simposio di Patologia Digitale sulle innovazioni e le intuizioni (12:00-13:00 ET) e un Simposio sugli Affari Medici incentrato sulla Eterogeneità del PD-L1 (17:30-19:00 ET).
Agilent Technologies (NYSE: A) presentará sus soluciones de patología digital en la Conferencia USCAP en Boston, del 22 al 27 de marzo de 2025. La empresa ha desarrollado un flujo de trabajo de patología digital de extremo a extremo en colaboración con Hamamatsu, PathAI, Proscia y Visiopharm, integrando software de patología de precisión impulsado por IA con soluciones de tinción automatizadas.
La exhibición contará con demostraciones en vivo de escaneo, gestión de imágenes y capacidades de análisis de imágenes impulsadas por IA. Los productos clave que se mostrarán incluyen el Magnis NGS Prep System y el NovoCyte Opteon Spectral Flow Cytometer.
Se programaron dos simposios para el 24 de marzo: un Simposio de Patología Digital sobre innovaciones y perspectivas (12:00-1:00 PM ET) y un Simposio de Asuntos Médicos centrado en la heterogeneidad de PD-L1 (5:30-7:00 PM ET).
Agilent Technologies (NYSE: A)는 2025년 3월 22일부터 27일까지 보스턴에서 열리는 USCAP 컨퍼런스에서 디지털 병리 솔루션을 선보일 예정입니다. 이 회사는 Hamamatsu, PathAI, Proscia 및 Visiopharm과 협력하여 AI 기반의 정밀 병리 소프트웨어와 자동 염색 솔루션을 통합한 종합 디지털 병리 워크플로를 개발했습니다.
전시회에서는 스캔, 이미지 관리 및 AI 기반 이미지 분석 기능에 대한 라이브 데모가 포함됩니다. 전시될 주요 제품으로는 Magnis NGS Prep System과 NovoCyte Opteon Spectral Flow Cytometer가 있습니다.
3월 24일에는 두 개의 심포지엄이 예정되어 있습니다: 혁신 및 통찰력에 대한 디지털 병리 심포지엄(오후 12:00-1:00 ET)과 PD-L1 이질성에 중점을 둔 의료 업무 심포지엄(오후 5:30-7:00 ET)입니다.
Agilent Technologies (NYSE: A) présentera ses solutions de pathologie numérique lors de la Conférence USCAP à Boston, du 22 au 27 mars 2025. L'entreprise a développé un flux de travail de pathologie numérique de bout en bout en collaboration avec Hamamatsu, PathAI, Proscia et Visiopharm, intégrant un logiciel de pathologie de précision piloté par IA avec des solutions de coloration automatisées.
La présentation mettra en avant des démonstrations en direct des capacités de numérisation, de gestion d'images et d'analyse d'images pilotées par IA. Les principaux produits présentés incluront le système de préparation Magnis NGS et le cytomètre de flux spectral NovoCyte Opteon.
Deux symposiums sont prévus pour le 24 mars : un symposium sur la pathologie numérique portant sur les innovations et les perspectives (12h00-13h00 ET) et un symposium sur les affaires médicales axé sur l'hétérogénéité du PD-L1 (17h30-19h00 ET).
Agilent Technologies (NYSE: A) wird seine digitalen Pathologielösungen auf der USCAP-Konferenz in Boston vom 22. bis 27. März 2025 präsentieren. Das Unternehmen hat in Zusammenarbeit mit Hamamatsu, PathAI, Proscia und Visiopharm einen umfassenden digitalen Pathologie-Workflow entwickelt, der KI-gesteuerte Präzisionspathologiesoftware mit automatisierten Färbelösungen integriert.
Die Präsentation wird Live-Demonstrationen von Scanning, Bildmanagement und KI-gesteuerten Bildanalysefähigkeiten umfassen. Zu den wichtigsten Produkten, die gezeigt werden, gehören das Magnis NGS Prep System und der NovoCyte Opteon Spectral Flow Cytometer.
Für den 24. März sind zwei Symposien geplant: ein Symposium zur digitalen Pathologie über Innovationen und Erkenntnisse (12:00-13:00 Uhr ET) und ein Symposium zu medizinischen Angelegenheiten mit Fokus auf PD-L1-Heterogenität (17:30-19:00 Uhr ET).
- Development of comprehensive AI-integrated digital pathology workflow
- Strategic partnerships with leading technology companies (Hamamatsu, PathAI, Proscia, Visiopharm)
- Enhanced automation capabilities reducing diagnostic time
- None.
In pathology, Agilent offers comprehensive tissue diagnostic solutions for analyzing tissue samples, often for diagnosing diseases such as cancer. In collaboration with Hamamatsu, PathAI, Proscia, and Visiopharm, Agilent has developed an innovative end-to-end digital pathology workflow. This solution integrates AI-driven precision pathology software with automated staining solutions, significantly improving diagnostic quality and efficiency. Agilent's workflow covers everything from scanning tissue samples to analyzing images and managing data, incorporating advanced technologies like AI to enhance accuracy and efficiency.
"Agilent's innovative pathology solutions are transforming health care by ensuring precise, timely, and reliable diagnoses. Our comprehensive digital pathology workflows and advanced staining technologies enable laboratories to deliver accurate and comprehensive results, facilitating faster and more effective treatments,” said Nina Green, vice president and general manager of the Clinical Diagnostics Division at Agilent. “By reducing the time from biopsy to diagnosis and enhancing diagnostic consistency, we help support better therapeutic decisions."
USCAP attendees are invited to live demonstrations of Agilent’s digital pathology solutions, including scanning, image management, and AI-driven image analysis. Covering primary, special, IHC, and ISH staining, Agilent’s automated, integrated, and advanced tissue staining solutions deliver consistent, high-quality results, helping laboratories enhance productivity and reduce the time from biopsy to diagnosis. Agilent will also showcase key products that play crucial roles in pathology labs including the Magnis NGS Prep System and the NovoCyte Opteon Spectral Flow Cytometer.
A Digital Pathology Symposium, “Advancing Diagnostics: Cutting-Edge Innovations and Insights in Digital Pathology,” will be held Monday, March 24, from 12:00–1:00 PM ET, featuring presenters including Dr. Douglas Clark and Jake Eden from Agilent, Dr. Orly Ardon from Hamamatsu, Dr. Dominique Coco from Proscia, Dr. Anil Parwani from Visiopharm, and Dr. Brian Robinson from PathAI. Additionally, a Medical Affairs Symposium, “PD-L1 Heterogeneity Across the Patient Journey,” will also be held Monday, March 24, from 5:30–7:00 PM ET, and presented by Dr. Matteo Fassan, professor of Pathology at the University of Padua in
For more information about these events and Agilent's pathology solutions, visit the USCAP Agilent booth #512.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great science to life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of
View source version on businesswire.com: https://www.businesswire.com/news/home/20250320022736/en/
Media Contact
Naomi Goumillout
Agilent Technologies
+1.978.314.1862
naomi.goumillout@agilent.com
Source: Agilent Technologies Inc.
FAQ
What new digital pathology solutions will Agilent (NYSE: A) showcase at USCAP 2025?
Who are Agilent's key partners in their digital pathology workflow solution?
When and where will Agilent's Digital Pathology Symposium take place at USCAP 2025?
What are the main benefits of Agilent's digital pathology solutions for laboratories?
